Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Amortization of Deferred Charges: 2020-2025

Historic Amortization of Deferred Charges for Maravai Lifesciences Holdings (MRVI) over the last 4 years, with Sep 2025 value amounting to $399,000.

  • Maravai Lifesciences Holdings' Amortization of Deferred Charges fell 47.08% to $399,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.9 million, marking a year-over-year decrease of 35.96%. This contributed to the annual value of $2.9 million for FY2024, which is 1.13% down from last year.
  • Latest data reveals that Maravai Lifesciences Holdings reported Amortization of Deferred Charges of $399,000 as of Q3 2025, which was up 2.05% from $391,000 recorded in Q2 2025.
  • In the past 5 years, Maravai Lifesciences Holdings' Amortization of Deferred Charges registered a high of $754,000 during Q3 2024, and its lowest value of $391,000 during Q2 2025.
  • In the last 3 years, Maravai Lifesciences Holdings' Amortization of Deferred Charges had a median value of $729,000 in 2023 and averaged $643,273.
  • Its Amortization of Deferred Charges has fluctuated over the past 5 years, first crashed by 96.56% in 2021, then increased by 13.61% in 2023.
  • Over the past 5 years, Maravai Lifesciences Holdings' Amortization of Deferred Charges (Quarterly) stood at $681,000 in 2021, then fell by 3.96% to $654,000 in 2022, then increased by 13.61% to $743,000 in 2023, then dropped by 11.44% to $658,000 in 2024, then tumbled by 47.08% to $399,000 in 2025.
  • Its Amortization of Deferred Charges was $399,000 in Q3 2025, compared to $391,000 in Q2 2025 and $461,000 in Q1 2025.